4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-18-049112
Chief Financial Officer bought 400 shares at an average $6.00 ($2,400)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bonner Michael Chief Financial Officer | 2018-08-28 | Purchase | +300 | $5.92 | $1,776 | 18,354 | D |
| Bonner Michael Chief Financial Officer | 2018-08-29 | Purchase | +100 | $6.24 | $624 | 18,454 | D |
| Open-market purchases · 400 sh · avg $6.00 · $2,400 | |||||||
Loading xslF345X03/doc4.xml…